TECXTectonic Therapeutic, Inc.

$635M

Q2 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$354,000

Operating Income

-$28M

Net Income

-$28M

EPS (Diluted)

$-7.70

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$29M

Free Cash Flow

-$29M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$146M

Total Liabilities

$28M

Stockholders' Equity

$118M

Cash & Equivalents

$132M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$354,000	-$299,000	-18.4%
Operating Income	-$28M	-$31M	+11.5%
Net Income	-$28M	-$31M	+10.6%

TECX Q2 2022 Earnings — Tectonic Therapeutic, Inc. Revenue & Financial Results | Market Cap Arena